Seòmar agus comataidhean

The Scottish Patient Safety Programme (SPSP) has developed a number of tools and resources to improve medicines safety. One area of focus has been on developing resources around the use of high risk medicines, and within high risk situations. The high risk medicines framework and discussion tool has been reviewed by the clinical team supporting Healthcare Improvement Scotland (HIS) to ensure they remain up to date and beneficial. There are also some more in-depth evaluations and updates of specific resources. The sick day rule cards are being updated in collaboration with the Quality Prescribing and Therapeutics Division of the Scottish Government and will be included in polypharmacy guidance, and HIS has commissioned the University of Strathclyde to complete a national evaluation of the Non-Steroidal Anti-Inflammatory Drugs (NSAID) safety bundles. This evaluation will be completed in the coming months and a report will be issued outlining the findings.

A programme of stakeholder engagement has taken place to develop our strategic approach to workforce planning for mental health and wellbeing. Our strategic approach, which will align with the Health and Social Care: National Workforce Strategy published March 2022, will be included within the forthcoming Mental Health and Wellbeing Strategy.

We continue to work closely with stakeholders to develop the Mental Health and Wellbeing Workforce Action Plan which will accompany the Strategy's delivery plan, with the intention of publishing in Autumn 2023.

In keeping with the commitment to bring forwar d a Bill this parliamentary year, the Circular Economy Bill will be introduced ahead of summer recess.

As at April, for outpatient appointments the median waiting time between referral and appointment is 236 days. The longest waiting time is 448 days.

The TSI Scotland Network is not a formally constituted group; it is a grouping of organisations with a shared purpose namely the TSIs. It does not have Office Bearers.

Some TSIs are partnerships where the role is shared across two or more organisations, others are single entities. Most of the organisations which form TSIs are registered charities, and often they are also registered companies. More information about the Network can be found at www.tsi.scot .

A list of the organisations which make up the TSI Network is given in the following table.

The Bus Taskforce was convened by the previous Minister for Transport to work on critical issues with bus stakeholders. It is reviewing and coordinating immediate activity to support patronage recovery, to address workforce retention and recruitment, and to ensure proactive communication and engagement with bus users as networks adapt post Covid. The work is expected to conclude in the coming months and a report of the Taskforce's work and recommendations will be published in Autumn 2023.

Five years on from the joint agreement between Scottish Government and the British Medical Association (BMA) on the 2018 GP contract, we have made significant progress in the implementation of Primary Care Improvement Plans (PCIPs). The Vaccination Transformation Programme element of the 2018 GP contract is complete.

While the Scottish Government will seek continuous improvement of our vaccination services, I would envisage neither a return to a model of default GP provision nor local models based on optional GP participation. This is because the aim of the Vaccination Transformation Programme was to ensure that GP practices are able to focus on the work only they can do, such as complex care and diagnosing undifferentiated presentations. Vaccinations can be administered in a wide range of different settings by a wide range of healthcare professionals.

The GP profession voted as a whole in 2018 in favour of not providing vaccinations and this position remains extant. There will always be exceptions to this of course, in rural areas and where the need to vaccinate quickly is paramount. Notwithstanding these exceptions, I would not anticipate making any fundamental changes to our vaccination model which are counter to our 2018 agreement with GPs about the future of the profession.

The following table shows Scottish Government staffing costs for Health Inequalities (HI) policy functions from 2020 to 2023, and the total over this period.

The High Risk Medicines Framework specifies some medicines and medicines groups and at the current time this does not include Parkinson’s medication. There is also a High Risk Medicines Discussion template that is not medicine specific and can be adapted and used by local teams to meet their needs. Parkinson’s medication can be reviewed and discussed within this framework to support local teams to discuss and prioritise improvement activities. All resources are reviewed regularly and the Scottish Patient Safety Programme (SPSP) welcomes further suggestions to add to or develop resources.

I refer the member to the answer to question S6W-17503 on 15 May 2023. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers